Nucleoside analog; specific inhibitor of hepatitis B virus (HBV) replication. Prepn: J. Smejkal, F. Sorm, Collect. Czech. Chem. Commun. 29, 2809 (1964); A. Holy, ibid. 37, 4072 (1972). Anti-HBV activity: M. L. Bryant et al., Nucleosides Nucleotides Nucleic Acids 20, 597 (2001) DOI PubMed. In vitro pharmacology: B. Hernandez-Santiago et al., Antimicrob. Agents Chemother. 46, 1728 (2002) DOI PubMed. Clinical evaluation in hepatitis B: C.-L. Lai et al., Hepatology 40, 719 (2004) DOI PubMed. Review of mechanism of action and pharmacology: D. N. Standring et al., Antivir. Chem. Chemother. 12, Suppl. 1, 119-129 (2001) PubMed; of clinical development: S.-H. B. Han, Expert Opin. Invest. Drugs 14, 511-519 (2005) DOI. See also Thymidine.
Antiviral.
Antiviral; Nucleosides/Nucleotides